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Abstract
Obesity has become a worldwide health problem. Orlistat, an inhibitor of pancreatic lipase, is currently approved as an anti-obesity drug. However,
gastrointestinal side effects caused by Orlistat may limit its use. In this study the inhibitory activities of dandelion (Taraxacum officinale) against 
pancreatic lipase in vitro and in vivo were measured to determine its possible use as a natural anti-obesity agent. The inhibitory activities of the
95% ethanol extract of T. officinale and Orlistat were measured using 4-methylumbelliferyl oleate (4-MU oleate) as a substrate at concentrations 
of 250, 125, 100, 25, 12.5 and 4 μg/ml. To determine pancreatic lipase inhibitory activity in vivo, mice (n=16) were orally administered with corn
oil emulsion (5 ml/kg) alone or with the 95% ethanol extract of T. officinale (400 mg/kg) following an overnight fast. Plasma triglyceride levels were
measured at 0, 90, 180, and 240 min after treatment and incremental areas under the response curves (AUC) were calculated. The 95% ethanol extract
of T. officinale and Orlistat, inhibited, porcine pancreatic lipase activity by 86.3% and 95.7% at a concentration of 250 μg/ml, respectively. T. officinale
extract showed dose-dependent inhibition with the IC50 of 78.2 μg/ml. A single oral dose of the extract significantly inhibited increases in plasma
triglyceride levels at 90 and 180 min and reduced AUC of plasma triglyceride response curve (p<0.05). The results indicate that T. officinale exhibits
inhibitory activities against pancreatic lipase in vitro and in vivo. Further studies to elucidate anti-obesity effects of chronic consumption of T. officinale
and to identify the active components responsible for inhibitory activity against pancreatic lipase are necessary.
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Introduction2)
Obesity, defined as the excessive accumulation of body fat that 
may impair health, has become a worldwide epidemic (Mokdad 
et al., 2003). Obesity is a major risk factor for cardiovascular 
disease including heart disease and stroke, diabetes mellitus, 
musculoskeletal disorders such as osteoarthritis, and some cancers 
such as breast, endometrial, prostate, and colon cancer (Aronne, 
1998). The fundamental cause of obesity is an energy imbalance 
between calorie intake and expenditure. Therefore, inhibition of 
digestion and absorption of dietary fat, the most concentrated 
source of energy, can be useful in treatment of obesity. In fact, 
Orlistat, a potent competitive inhibitor of gastric and pancreatic 
lipase, is available as an anti-obesity drug (Ballinger & Peikin, 
2002; Hochuli et al., 1987; Jandacek & Woods, 2004; Weibel 
et al., 1987). However, this medication is associated with a 
greater incidence of gastrointestinal side effects (Birari & Bhutani, 
2007; Weigle, 2003). Therefore, numerous studies have evaluated 
natural products with pancreatic lipase inhibitory activity, including 
plant materials, as an alternative anti-obesity agent (Arai et al., 
1999; Han et al., 2001; Han et al., 2002; Kim, 2007; Kurihara 
et al., 2003; Kurihara et al., 2006). Dietary teasaponin (Han et 
al., 2001), saponins from Platycodi Radix (Han et al., 2002), 
and onion skin extract (Kim, 2007) were reported to decrease 
postprandial plasma triglyceride response after lipid load and 
showed anti-obesity effects in animals fed high fat diets. 
Dandelion (Taraxacum officinale)  is a herbaceous perennial 
plant of the family Asteraceae (Compositae). T. officinale has 
been used as a phytomedicine due to its choleretic, antirhemetic, 
diuretic, and anti-inflammatory properties (Bisset, 1994). It has 
been reported that T. officinale exhibits anti-inflammatory activity 
(Mascolo et al., 1987) and anti-tumor activity (Williams et al., 
1996). Antioxidant activity of T. officinale has been demonstrated 
in vitro (Hu & Kitts, 2005) and in vivo (Cho et al., 2003). T. 
officinale has been reported to have hypolipidemic effects in rats 
fed a high cholesterol diet (Cho et al., 2000) and streptozotocin- 
induced diabetic rats (Cho et al., 2002). 
However, the effect of this plant on the activity of pancreatic 
lipase has not yet been examined. Thus, in this study we measured 
the pancreatic lipase inhibitory activity of T. officinale in vitro 
and in vivo to evaluate its possible use as an anti-obesity agent.
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Fig. 1. Dose-dependent inhibition of pancreatic lipase activity of Taraxacum 
officinale. extract and Orlistat. The inhibitory activities of the 95% ethanol extract 
of Taraxacum officinale or Orlistat were measured at concentrations of 250, 125, 
100, 25, 12.5 and 4 μg/ml.  □, Orlistat; ◆, T. officinale. Values represent mean
± SD  of  triplicate  measurements.
Materials and Methods 
Reagents 
Orlistat was obtained from Roche Korea (Seoul, Korea). Corn 
oil was purchased from Cheiljedang (Seoul, Korea). Porcine 
pancreatic lipase, 4-methylumbelliferyl oleate (4-MU oleate), as 
well as the assay kit for triglycerides and all other reagent grade 
chemicals were purchased from Sigma (St. Louis, MO, USA). 
Preparation of the ethanol extract 
Young leaves of T. officinale were obtained from a local market 
in Changnyung-gun, Korea. The leaves were freeze-dried, 
powdered, and extracted with ten volumes of 95% ethanol for 
12 hr three times at room temperature. The solvent was removed 
by rotary evaporation at 40℃.
Measurement of pancreatic lipase inhibitory activity in vitro
The inhibitory activity against pancreatic lipase was measured 
using 4-MU oleate as a substrate (Thompson, 1978). The reaction 
mixture consisted of 50 μL 0.1 mM 4-MU oleate, 20 μL McIlvane 
buffer (0.1 M citrate-Na2 HPO4, pH 7.4), and 5 μL of sample 
solution. Porcine pancreatic lipase (25 μL) was added to the 
reaction mixture and the final volume was adjusted to 0.1 ml. 
After the mixture was incubated at 37℃ for 10 min, the amount 
of 4-MU released by the lipase was measured using a 
fluorescence multi-detection reader (Bio-Tek Instruments, Inc., 
Winooski, VT, USA) at an excitation wavelength of 320 nm and 
an emission wavelength of 450 nm. The inhibitory activities of 
the T. officinale. extract and Orlistat, a positive control against 
pancreatic lipase were measured at concentrations of 250, 125, 
100, 25, 12.5 and 4 μg/ml. The measurements were performed 
in triplicate, and the IC50 value, the concentration of the extract 
that results in 50% inhibition of maximal activity was determined.
Animals
Five week-old male ICR mice weighing between 20 and 25 
g were purchased from Bio Genomics, Inc. (Seoul, South Korea). 
All animals were fed a commercial chow ad libitum for 2 wk 
after arrival. Mice were housed individually in stainless steel 
wire-bottomed cages and located in a room where temperature 
(23-27℃), humidity (50-60%), and lighting cycle (12 hr light/ 
dark cycle) were controlled. Mice (28-35 g, n=16) were then 
randomly divided into two groups.
Measurement of plasma triglyceride levels after oral administration 
of a lipid emulsion to mice
Following an overnight fast, the animals were fed corn oil 
emulsion (5 ml/kg) alone or oil emulsion with 95% ethanol 
extract of T.officinale  (400 mg/kg). The oil emulsion was 
composed of 80 mg cholic acid, 2 mg cholesteryl oleate, 6 ml 
saline, and 6 ml corn oil. Food was withheld during the test. 
Blood samples were collected from the ophthalmic venous plexus 
0, 90, 180, and 240 min after the oral administration and 
centrifuged at 2,000 x g for 15 min. Plasma triglyceride levels 
were measured using a commercial triglyceride assay kit and 
were expressed as increments from the baseline. Incremental 
areas under the response curves (AUC) were calculated using 
the trapezoidal rule with fasting levels as the baseline. The 
experiments were performed according to the guidelines of 
animal experimentation approved by the Animal Resource Center 
at Inje University, Korea.
Statistics
All data are expressed as mean ± standard deviation (SD). All 
statistical analyses were performed using SAS (version 8.02). 
Differences in incremental plasma triglyceride levels and AUC 
between control group and T. officinale group were assessed 
using Student's t-test. Significance was defined as p<0.05. 
Results
Dose-dependent inhibition of pancreatic lipase activity 
The inhibitory activities of 95% ethanol extract of T. officinale 
against porcine pancreatic lipase are shown in Fig. 1. The T. 
officinale  extract  inhibited pancreatic lipase activity by 86.3, 202 Pancreatic Lipase Inhibitory Activity of Taraxacum officinale
Fig. 2. Increase in plasma triglyceride after administration of Taraxacum officinale
extract to mice. In the control group (□), corn oil emulsion (5 ml/kg) was administered 
orally to mice after an overnight fast. In the Taraxacum officinale. group (◆), corn 
oil  emulsion  (5  ml/kg)  plus  95%  ethanol  extract  of  T. officinale.  (400  mg/kg)  was 
administered  orally to  mice after  an  overnight  fast.  Values  represent  mean ± SD.
*Significantly  different  at  P<0.05
Table 1. Area under the curve (AUC) of postprandial triglyceride responses of 
mice 
Group AUC (mg․min/dl)
Control group 11,068 ± 2,054
Taraxacum officinale group 8,504 ± 1,950*
Control  group:  Corn oil  emulsion  (5  ml/kg) was  administered  orally to mice after 
an  overnight  fast.
Taraxacum officinale group: Corn oil emulsion (5 ml/kg) plus 95% ethanol extract 
of T. officinale. (400 mg/kg) was administered orally to mice after an overnight fast. 
AUC:  Area  under  the  response  curves.
Values  represent  mean ± SD  (n=8). 
*Significantly  different  at  p＜0.05
63.0, 56.5, 34.1, 21.9, and 8.1% at concentrations of 250, 125, 
100, 25, 12.5 and 4 μg/ml  in vitro, respectively. Orlistat, a 
pancreatic lipase inhibitor used as an anti-obesity agent, inhibited 
the enzyme activity by 95.7 and 90.4% at concentrations of 250 
and 4 μg/ml, respectively. The T. officinale extract and Orlistat 
had IC50  values of 78.2 μg/ml and 0.22 μg/ml, respectively.
Effect of T. officinale extract on postprandial triglyceride 
response
Plasma triglyceride responses to a single oral dose of corn oil 
emulsion (5 ml/kg) alone or the oil emulsion with T. officinale 
extract (400 mg/kg) in ICR mice are shown in Fig. 2. Incremental 
plasma triglyceride levels of mice that consumed the oil emulsion 
alone reached a peak (76.9 ± 12.6 mg/dl) at 180 min. Consumption 
of T. officinale extract significantly decreased incremental plasma 
triglyceride levels at 90 and 180 min (p<0.05). The AUC for 
triglyceride response was significantly lower in the T. officinale 
group (8,504 ± 1,950 mg·min/dl) than in the control group 
(11,068 ± 2,054 mg·min/dl, p<0.05, Table 1).
Discussion
Pancreatic lipase is the key enzyme for dietary fat digestion 
(Olshansky et al., 2005), and inhibition of the enzyme could be 
an effective way to alter fat absorption. In fact, Orlistat, pancreatic 
lipase inhibitor and Sibutramine, an appetite suppressor are the 
only two anti-obesity medications currently approved (Jandacek 
& Woods, 2004). However, because Orlistat can result in 
undesirable side effects, such as fecal incontinence, flatulence, 
and steatorrhea, its use may be limited (Birari & Bhutani, 2007; 
Weigle, 2003). Therefore, it may be worthwhile to search the 
natural substances that show potent inhibitory activity against 
pancreatic lipase and have fewer side effects. Alpinia officinarum 
(Shin  et al., 2003), grape seed extract (Moreno et al., 2003), 
green tea extract (Juhel et al., 2000), mango leaf and stem bark 
extracts (Moreno et al., 2006), and onion skin (Kim, 2007) 
showed potent inhibitory activity against pancreatic lipase.
In this study, we investigated the inhibitory activity of T. 
officinale against porcine pancreatic lipase in vitro. At a 
concentration of 250 μg/ml, the T. officinale extract exhibited 
90.2% of the inhibition activity of Orlistat against pancreatic 
lipase, and T. officinale inhibited pancreatic lipase in a dose- 
dependent manner with an IC50 of 78.2 μg/ml (Fig. 1). Orlistat 
showed IC50 of 0.22 μg/ml Orlistat was reported to show IC50 
of 0.14 μg/ml (Weibel et al., 1987). We determined the effect 
of T. officinale on postprandial blood triglyceride in mice after 
consumption of corn oil emulsion load. The T. officinale extract 
(400 mg/kg) significantly suppressed incremental plasma 
triglyceride at 90 and 180 min (Fig. 2). Arai et al. (1999) reported 
that n-hexane fraction isolated from Eugenia uniflora extract 
showed pancreatic lipase inhibitory activity in vitro and 
improving effect on postprandial hypertriglyceridemia in mice 
administered with corn oil emulsion. Kurihara et al. (2003) 
reported that Cyclocarya paliurus (Batal) Iljinskaja extract with 
pancreatic lipase inhibitory activity inhibited postprandial plasma 
triglyceride increase at 180 min after administration of lard oil 
or olive oil in mice without influencing postprandial plasma free 
fatty acid levels suggesting that utilization of triglyceride was 
not changed. In this study T. officinale extract significantly 
decreased AUC for the postprandial triglyceride response curve. 
These data demonstrate that T. officinale exerts pancreatic lipase 
inhibitory activity in vivo to decrease postprandial triglyceride 
levels. AUC after a test meal is extensively used as index of 
the postprandial triglyceride response (Karamanos et al., 2001). 
The limitation of this study is that we could not distinguish 
contribution of inhibition of dietary fat absorption and increase 
of triglyceride clearance to the reduction of postprandial plasma 
triglyceride response. Further study to measure the effect of T. 
officinale on postprandial plasma free fatty acid and lipoprotein 
lipase activity would be necessary to determine the effect on 
triglyceride clearance. 
T. officinale leaf was reported to contain flavonoids such as 
luteolin (Williams et al., 1996) and it was demonstrated Jian Zhang et al. 203
flavonoids could have pancreatic lipase inhibitory activity 
(Moreno et al., 2006; Shin et al., 2003; Yamamoto et al., 2000). 
Further study to identify the active compounds which inhibit 
pancreatic lipase from T. officinale leaf  could be valued.
Obesity is associated with increased risks for some chronic 
degenerative diseases and decreased life expectancy (Mokdad et 
al., 2003; Olshansky et al., 2005). A combination of diet therapy, 
exercise, and behavior modification is the standard regimen for 
the treatment of obesity, and medication therapy can be used 
in conjunction with such lifestyle changes. Since only a few 
medications have been approved as effective and safe (Jandacek 
& Woods, 2004), extensive studies have been carried out to 
develop alternative anti-obesity drugs. Our data suggest that T. 
officinale has potential to be used as an anti-obesity agent. 
In conclusion, T. officinale showed strong pancreatic lipase 
inhibitory activity in vitro and in vivo. Further studies to elucidate 
anti-obesity effects of chronic consumption of T. officinale and 
to identify the active components responsible for inhibitory 
activity against pancreatic lipase are necessary.
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